Press release

Atrogi was awarded a 5 MSEK grant. This very prestigeful grant from the SWElifes accelerator program was received in fierce competition with other applicants. The grant will be used to help bring one of the compounds that Atrogis is developing for the treatment of type 2 diabetes to the clinic.